Aspira Pathlab and Diagnostics Ltd Q1FY23 loss at Rs. 28.52 lakhs

Aspira Pathlab & Diagnostics Limited has reported Standalone financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 3.0319 crores during the period ended June 30, 2022 as compared to Rs. 5.4767 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. -0.2852 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 1.4428 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. -0.28 for the period ended June 30, 2022 as compared to Rs. 1.40 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 3.0319 crs	₹5.4767 crs	-44.64%
Net Profit	₹-0.2852 crs	₹1.4428 crs	-119.77%
EPS	₹-0.28	₹1.40	-120.00%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 3.0319 crores during the period ended June 30, 2022 as compared to Rs.5.9060 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.-0.2852 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.2.0034 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.-0.28 for the period ended June 30, 2022 as compared to Rs.1.95 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 3.0319 crs	₹5.9060 crs	-48.66%
Net Profit	₹-0.2852 crs	₹2.0034 crs	-114.24%
EPS	₹-0.28	₹1.95	-114.36%

Shares of Aspira Pathlab & Diagnostics Limited was last trading in BSE at Rs. 51.90 as compared to the previous close of Rs. 51.00. The total number of shares traded during the day was 349 in over 5 trades.

The stock hit an intraday high of Rs. 53.50 and intraday low of 51.00. The net turnover during the day was Rs. 17861.00.

Source : Equity Bulls

Keywords

AspiraPathlabandDiagnostics Q1FY23 ResultUpdate